Counterpoint: The evidence does not support universal screening and treatment in children
- 1 September 2015
- journal article
- review article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 9 (5) , S101-S106
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Disease-modifying Antirheumatic Drug Use in the Treatment of Juvenile Idiopathic Arthritis: A Cross-sectional Analysis of the CARRA RegistryThe Journal of Rheumatology, 2012
- Safely Doing Less: A Missing Component of the Patient Safety DialoguePediatrics, 2011
- Use of atorvastatin in systemic lupus erythematosus in children and adolescentsArthritis & Rheumatism, 2011
- Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trialsQJM: An International Journal of Medicine, 2010
- Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and pharmacologyMedical Hypotheses, 2009
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-AnalysisDiabetes Care, 2009
- Short-term Change in Body Mass Index in Overweight Adolescents Following Cholesterol ScreeningArchives of Pediatrics & Adolescent Medicine, 2009
- Concentrations of Low-Density Lipoprotein Cholesterol and Total Cholesterol Among Children and Adolescents in the United StatesCirculation, 2009
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002